Starpharma Holdings Ltd (SPHRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2022 | 06-2022 | 12-2021 | 06-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -11,720 | N/A | -14,744 | N/A |
| Depreciation Amortization | N/A | 783 | N/A | 699 | N/A |
| Other Working Capital | N/A | -102 | N/A | -412 | N/A |
| Other Operating Activity | -3,340 | 1,490 | -8,191 | 3,392 | -3,932 |
| Operating Cash Flow | $-3,340 | $-9,549 | $-8,191 | $-11,065 | $-3,932 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -305 | -607 | -141 | -184 | -79 |
| Investing Cash Flow | $-305 | $-607 | $-141 | $-184 | $-79 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -224 | 2,342 | 1,479 | 34,598 | 34,149 |
| Financing Cash Flow | $-224 | $2,342 | $1,479 | $34,598 | $34,149 |
| Exchange Rate Effect | 1 | 136 | 117 | -600 | -705 |
| Beginning Cash Position | 32,831 | 43,893 | 44,074 | 22,456 | 21,994 |
| End Cash Position | 28,964 | 36,216 | 37,339 | 45,206 | 51,427 |
| Net Cash Flow | $-3,867 | $-7,677 | $-6,736 | $22,749 | $29,433 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,340 | -9,549 | -8,191 | -11,065 | -3,932 |
| Free Cash Flow | -3,340 | -9,549 | -8,191 | -11,065 | -3,932 |